426 related articles for article (PubMed ID: 19003550)
21. Clinical and economic analysis of spa therapy in Parkinson's disease.
Brefel-Courbon C; Desboeuf K; Thalamas C; Galitzky M; Senard JM; Rascol O; Montastruc JL
Mov Disord; 2003 May; 18(5):578-84. PubMed ID: 12722173
[TBL] [Abstract][Full Text] [Related]
22. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
Gallagher DA; Lees AJ; Schrag A
Mov Disord; 2010 Nov; 25(15):2493-500. PubMed ID: 20922807
[TBL] [Abstract][Full Text] [Related]
23. Independent validation of the non motor symptoms scale for Parkinson's disease in Brazilian patients.
Carod-Artal FJ; Martinez-Martin P
Parkinsonism Relat Disord; 2013 Jan; 19(1):115-9. PubMed ID: 22981311
[TBL] [Abstract][Full Text] [Related]
24. Caregiver burden in Parkinson's disease.
Martínez-Martín P; Forjaz MJ; Frades-Payo B; Rusiñol AB; Fernández-García JM; Benito-León J; Arillo VC; Barberá MA; Sordo MP; Catalán MJ
Mov Disord; 2007 May; 22(7):924-31; quiz 1060. PubMed ID: 17238193
[TBL] [Abstract][Full Text] [Related]
25. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.
Gómez-Esteban JC; Zarranz JJ; Lezcano E; Tijero B; Luna A; Velasco F; Rouco I; Garamendi I
Eur Neurol; 2007; 57(3):161-5. PubMed ID: 17213723
[TBL] [Abstract][Full Text] [Related]
26. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
27. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
28. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
29. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
30. Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease.
Kurtis MM; Rodriguez-Blazquez C; Martinez-Martin P;
Parkinsonism Relat Disord; 2013 Dec; 19(12):1152-5. PubMed ID: 23953775
[TBL] [Abstract][Full Text] [Related]
31. Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease.
Bach JP; Riedel O; Klotsche J; Spottke A; Dodel R; Wittchen HU
J Neurol Sci; 2012 Mar; 314(1-2):41-7. PubMed ID: 22133477
[TBL] [Abstract][Full Text] [Related]
32. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O;
Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403
[TBL] [Abstract][Full Text] [Related]
33. Major depression and health-related quality of life in Parkinson's disease.
Jones CA; Pohar SL; Patten SB
Gen Hosp Psychiatry; 2009; 31(4):334-40. PubMed ID: 19555793
[TBL] [Abstract][Full Text] [Related]
34. Patient-reported autonomic symptoms in Parkinson disease.
Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; van Hilten JJ
Neurology; 2007 Jul; 69(4):333-41. PubMed ID: 17646625
[TBL] [Abstract][Full Text] [Related]
35. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease.
Valldeoriola F; Morsi O; Tolosa E; Rumià J; Martí MJ; Martínez-Martín P
Mov Disord; 2007 Nov; 22(15):2183-91. PubMed ID: 17724747
[TBL] [Abstract][Full Text] [Related]
36. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study.
Coduras A; Rabasa I; Frank A; Bermejo-Pareja F; López-Pousa S; López-Arrieta JM; Del Llano J; León T; Rejas J
J Alzheimers Dis; 2010; 19(2):601-15. PubMed ID: 20110605
[TBL] [Abstract][Full Text] [Related]
37. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
[TBL] [Abstract][Full Text] [Related]
38. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
39. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286
[TBL] [Abstract][Full Text] [Related]
40. Contribution of aging to the severity of different motor signs in Parkinson disease.
Levy G; Louis ED; Cote L; Perez M; Mejia-Santana H; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Marder K
Arch Neurol; 2005 Mar; 62(3):467-72. PubMed ID: 15767513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
